Anti-osteoporosis therapy and fracture healing. - Wikidata - wikimedia - TriplyDB

Anti-osteoporosis therapy and fracture healing.

Anti-osteoporosis therapy and fracture healing.

http://www.wikidata.org/entity/Q38017621

about

Ordinary and Activated Bone Grafts: Applied Classification and the Main Features.Cross-talk of MicroRNA and hydrogen sulfide: A novel therapeutic approach for bone diseases.How do bisphosphonates affect fracture healing?Development of nanomaterials for bone-targeted drug delivery.Effects of Teriparatide Compared with Risedronate on Recovery After Pertrochanteric Hip Fracture: Results of a Randomized, Active-Controlled, Double-Blind Clinical Trial at 26 Weeks.Assessment of Osteoporosis in Injured Older Women Admitted to a Safety-Net Level One Trauma Center: A Unique Opportunity to Fulfill an Unmet Need.Implementation of a standardized protocol to manage elderly patients with low energy pelvic fractures: can service improvement be expected?Systemic Treatment with Strontium Ranelate Does Not Influence the Healing of Femoral Mid-shaft Defects in Rats.Fracture healing: a consensus report from the International Osteoporosis Foundation Fracture Working Group.Undisturbed local bone formation capacity in patients with atypical femoral fractures: a case series.Better Osteoporotic Fracture Healing with Sintered Dicalcium Pyrophosphate (SDCP) Treatment: A Rat Femoral Fracture Model.Modulation of Osteoclast Interactions with Orthopaedic Biomaterials.

P2860

Q36327911-8B45DD39-C849-43F3-B5A1-9FF324BAD677 Q38670631-750B0E78-FC40-4579-A90E-5F3AB5C774D2 Q38696914-07D8608C-6CC9-45D3-BFCB-F7E1D690000C Q39294078-41979694-1571-419D-8F1B-382498F3FB6D Q43782888-A29FFF01-B361-4741-8415-57EFF59788E3 Q46098285-6102C29A-1CBD-4D08-B02E-7F158EA48D76 Q47755708-1C9F72B7-B6A7-426D-8F3B-B64C3AFB239A Q48108259-234A3EFB-F4F1-42F5-BBEA-C93FAB0E1594 Q48822821-1F5444C9-3EF4-4397-B047-C9B8366D8BA5 Q50671913-85921104-33F0-4794-87C3-D2D7068E8A04 Q51140195-D843D18A-EFC3-499B-BB52-C4EC5FF696C0 Q55111648-6B467BAD-2B3C-4748-954C-634DD33DCC79

P2860

Anti-osteoporosis therapy and fracture healing.

http://www.wikidata.org/entity/Q38017621

description

article científic

@ca

article scientifique

@fr

articol științific

@ro

articolo scientifico

@it

artigo científico

@gl

artigo científico

@pt

artigo científico

@pt-br

artikel ilmiah

@id

artikull shkencor

@sq

artículo científico

@es

name

Anti-osteoporosis therapy and fracture healing.

@en

type

label

Anti-osteoporosis therapy and fracture healing.

@en

prefLabel

Anti-osteoporosis therapy and fracture healing.

@en

P1433

Q38017621-54564A4A-C27A-4817-B6F3-B95A0DC12C1E

P1476

Q38017621-5323081A-25BF-4F97-A84C-BB8B582EE554

P2093

Q38017621-C8F73181-F138-42B7-9907-269A612B9BC4

Q38017621-DD0B630B-1E80-41AB-87DB-3AFDB12F41F7

P2860

Q38017621-018F3D1C-B894-4F6D-8A97-F04F68C19F13

Q38017621-01F2C2BD-DF79-4B6B-893C-EA4C8FFF8998

Q38017621-03F731D4-6892-4C35-AC9C-9FA87233AE2B

Q38017621-07186E9B-35F9-44D5-A4DE-B7894E01F5A8

Q38017621-0A995900-2326-498D-930E-77D8D32E6EFB

Q38017621-1CA11CC5-995F-4A72-A538-CA1811FE1FCE

Q38017621-2CEF43F9-E5F3-4D44-9A67-83C849ABCD2A

Q38017621-34E72D57-4F95-40F7-8CD7-35B338C244DB

Q38017621-3690CD3F-A2B7-4B3C-89D3-7E8366251268

Q38017621-39283707-D07A-49EB-AA79-1415DCF455D0

P2888

Q38017621-D3CC5D75-3190-40A9-8547-B5A79561FF04

P304

Q38017621-E223B0DA-ED00-47D0-A40E-5390855ACCFF

P31

Q38017621-DB64878F-66C4-424C-8E36-B1E3D774AEB8

P356

Q38017621-73D17B65-CE5D-46A5-B763-86B0DCB959E1

P433

Q38017621-202651DA-5683-48AA-958C-C43C665FE76E

P478

Q38017621-D211D8B1-A92F-4458-8E5F-44507FF5D7C1

P577

Q38017621-3FEB2EA2-0638-4035-924C-107E0F1A5B12

P6179

Q38017621-0DACFE5F-B0DD-4212-B4A4-33AE63D07FFA

P698

Q38017621-C7A7A4D8-745A-400C-BF6C-D97B43F0F6C3

P921

Q38017621-BA0FC8E6-7F30-46A7-AFC0-4848AD0188E0

P356

S00402-012-1558-8

P1433

Archives of Orthopaedic and Trauma Surgery

P1476

Anti-osteoporosis therapy and fracture healing.

@en

P2093

Nicola L Fazzalari

http://www.w3.org/2001/XMLSchema#string

Sune Larsson

http://www.w3.org/2001/XMLSchema#string

P2860

Sclerostin antibody treatment increases bone formation, bone mass, and bone strength in a rat model of postmenopausal osteoporosis

Intermittent parathyroid hormone (1-34) treatment increases callus formation and mechanical strength of healing rat fractures.

Mechanisms for the enhancement of fracture healing in rats treated with intermittent low-dose human parathyroid hormone (1-34).

Increases in callus formation and mechanical strength of healing fractures in old rats treated with parathyroid hormone.

Optimal timing of a single dose of zoledronic acid to increase strength in rat fracture repair.

Refining animal models in fracture research: seeking consensus in optimising both animal welfare and scientific validity for appropriate biomedical use.

Enhanced chondrogenesis and Wnt signaling in PTH-treated fractures.

Bolus or weekly zoledronic acid administration does not delay endochondral fracture repair but weekly dosing enhances delays in hard callus remodeling.

Comparison of effects of the bisphosphonate alendronate versus the RANKL inhibitor denosumab on murine fracture healing.

Incidence of stress fractures of the femoral shaft in women treated with bisphosphonate.

P2888

s00402-012-1558-8

P304

291-297

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S00402-012-1558-8

http://www.w3.org/2001/XMLSchema#string

P433

2

http://www.w3.org/2001/XMLSchema#string

P478

134

http://www.w3.org/2001/XMLSchema#string

P577

2012-06-09T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P6179

1033390414

http://www.w3.org/2001/XMLSchema#string

P698

22684739

http://www.w3.org/2001/XMLSchema#string

P921